全文获取类型
收费全文 | 44252篇 |
免费 | 3331篇 |
国内免费 | 1157篇 |
专业分类
耳鼻咽喉 | 146篇 |
儿科学 | 1987篇 |
妇产科学 | 305篇 |
基础医学 | 4110篇 |
口腔科学 | 348篇 |
临床医学 | 4608篇 |
内科学 | 12669篇 |
皮肤病学 | 249篇 |
神经病学 | 504篇 |
特种医学 | 2526篇 |
外国民族医学 | 1篇 |
外科学 | 4428篇 |
综合类 | 7283篇 |
现状与发展 | 3篇 |
预防医学 | 2243篇 |
眼科学 | 166篇 |
药学 | 3958篇 |
28篇 | |
中国医学 | 2090篇 |
肿瘤学 | 1088篇 |
出版年
2024年 | 86篇 |
2023年 | 714篇 |
2022年 | 1275篇 |
2021年 | 1757篇 |
2020年 | 1764篇 |
2019年 | 1535篇 |
2018年 | 1586篇 |
2017年 | 1578篇 |
2016年 | 1534篇 |
2015年 | 1658篇 |
2014年 | 2945篇 |
2013年 | 3043篇 |
2012年 | 2757篇 |
2011年 | 2862篇 |
2010年 | 2402篇 |
2009年 | 2324篇 |
2008年 | 2380篇 |
2007年 | 2398篇 |
2006年 | 2144篇 |
2005年 | 1848篇 |
2004年 | 1408篇 |
2003年 | 1127篇 |
2002年 | 910篇 |
2001年 | 877篇 |
2000年 | 691篇 |
1999年 | 613篇 |
1998年 | 563篇 |
1997年 | 485篇 |
1996年 | 366篇 |
1995年 | 389篇 |
1994年 | 349篇 |
1993年 | 265篇 |
1992年 | 248篇 |
1991年 | 191篇 |
1990年 | 189篇 |
1989年 | 143篇 |
1988年 | 156篇 |
1987年 | 155篇 |
1986年 | 119篇 |
1985年 | 155篇 |
1984年 | 137篇 |
1983年 | 49篇 |
1982年 | 135篇 |
1981年 | 90篇 |
1980年 | 72篇 |
1979年 | 62篇 |
1978年 | 52篇 |
1977年 | 48篇 |
1976年 | 35篇 |
1974年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
《Gaceta sanitaria / S.E.S.P.A.S》2015,29(5):390-392
Chronic obstructive pulmonary disease (COPD) is a significant health problem in developed countries. We aimed to estimate the prevalence of COPD in a single Spanish healthcare area. We also aimed to assess if there are any differences in prevalence and spirometry use among primary care services by utilizing already registered information. We designed a cross-sectional study to determine the prevalence of COPD and the performance of spirometries in each primary care service. A total of 8,444 patients were diagnosed with COPD, with a prevalence of 2.6% for individuals older than 39 years. The prevalence increased with age and was much higher in men. Significant heterogeneity was found in the prevalence of COPD and spirometry use among primary care services. COPD was underdiagnosed and there was wide variability in spirometry use in our area. Greater efforts are needed to diagnose COPD in order to improve its clinical outcomes and to refine registries so that they can be used as reliable sources of information 相似文献
22.
23.
25.
BackgroundComplete surgical removal is currently considered to be the best treatment option for pulmonary sarcomatoid carcinoma (PSC) especially in early stage operable disease; however, the reported recurrence-free survival is low. Benefits of adjuvant chemotherapy in PSC patients are still controversial, and there is no obvious agreement on the optimal treatment modalities of this disease. Therefore, we aimed to investigate the prognosis in terms of overall survival (OS) in patients with PSC who received adjuvant chemotherapy.MethodsThe review protocol was registered in PROSPERO (CRD42022306084). Patients with PSC who underwent surgical therapy with or without adjuvant chemotherapy were included into the meta-analysis. Hazard ratios (HR) with 95% confidence intervals (CIs) for OS were pooled and ROBINS-I tool was used to assess risk of bias of the included studies.ResultsWe identified four retrospective cohort studies with 6768 records from MEDLINE, Embase, and CENTRAL databases up to 9th September 2021, and altogether 1835 patients were included to the analysis. The present meta-analysis shows that patients receiving adjuvant chemotherapy had a significantly longer OS than patients who underwent surgical treatment alone (HR = 0.5657, 95%CI: 0.4391–0.7290, p < 0.0001).ConclusionsDespite the limited information on the chemotherapy regimens in the included studies, patients with PSC may benefit from adjuvant chemotherapy. More publications are required to evaluate and compare efficient adjuvant chemotherapy protocols in PSC cases. 相似文献
26.
27.
28.
29.
目的 了解2009-2019年西安市肺结核的流行特征及治疗转归情况,为完善西安市肺结核防治策略提供依据。方法 收集2009-2019年《传染病信息管理系统》中登记的肺结核患者病案信息数据,通过描述性研究方法对肺结核流行病学特征和治疗转归情况进行分析。结果 2009-2019年间西安市肺结核年平均发病率为49.06/10万。郊县、郊区、城区肺结核年平均发病率分别为54.13/10万、47.46/10万和46.19/10万;男性发病率是女性的1.85倍。职业分布排在前5位的为农民(47.48%),家政、家务及待业(14.65%),离退人员(9.55%),学生(8.63%)和工人(5.23%)。利福平敏感或耐药性未知患者的成功治疗率平均为98.03%,利福平耐药患者治疗成功率为51.47%。结论 西安市近年来肺结核发病率和治疗率呈增长趋势,利福平耐药患者治疗成功率较低,要加强对重点人群的健康促进工作,加大肺结核发现力度及患者治疗管理工作。 相似文献
30.
The association between the decreased expression levels of FOXJ1 and the activation of NF-κB pathway in interstitial lung disease of MRL/Lpr mice 下载免费PDF全文
Background: Pulmonary manifestations of systemic lupus erythematosus (SLE) are appearing in 4-5% of patients involving lung in almost half of the cases during the disease course. Objective: We compared the autoimmune pulmonary inflammation in the lung tissue of mice to determine the association between decreased expression levels of Forkhead Box J1 (FOXJ1) and the activation of the NF-κB pathway in autoimmune pulmonary inflammation of MRL/Lpr mice. Methods: The female BALB/c mice (n=6) and MRL/Lpr mice (n=30) were divided into 5 groups including a control group (BALB/c), and five MRL/Lpr mice groups (8W, 12W, 16W, 24W, and 32W). The infiltration of the inflammatory cells was determined in lung tissue by performing the histological analysis. The western blotting was used to examine the expression levels of the age-related FOXJ1, and p50 and p65 proteins in the lungs of MRL/Lpr mice. The expression levels of MMP2 and MMP9 were determined via immunohistochemistry and immunofluorescence. Results: There were severe infiltrates of lung cells with high levels of tracheal damage, perivascular injury and interstitial inflammatory cell infiltration when the MRL/Lpr mice from 16w to 32w comparing to the 8w old healthy MRL/Lpr mice in the control group (p <0.05). Moreover, the reduced expression levels of FOXJ1 were associated with the activation of the NF-κB pathway in interstitial lung disease of MRL/Lpr mice via the modulation of p50 and p65. In addition, the expression levels of MMP2 and MMP9 pro-inflammation factors increased in the lungs of the MRL/Lpr mice from 16w to 32w. Conclusions: The expression level of FOXJ1 might be an indicator of the degree of lung disease in lupus-prone mice. 相似文献